An Open Label, Randomized Clinical Trial of Unani Formulation and Autologous Serum Therapy (AST) in the management ofShara-e-Muzmin (Chronic Urticaria) - NI

Department of Amraze Jild wa Zohrawiya Ajmal Khan Tibbiya College and Hospital AMU Aligarh0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年8月19日

研究概览

暂无简介。

•Clinically diagnosed patients of Chronic Urticaria (Urticaria of more than 6 weeks); with clinical features of erythema, itching and wheals of any grade.
•Patients of either sex in the age group of 18 years onwards.
•Patients who have agreed to sign the written informed consent and follow the protocol.

•Patients with other skin diseases like psoriasis, eczema, etc. by history and examination.
•Patients of urticaria presenting with features of angioedema.
•Patients suffering from any other systemic diseases, such as HTN, DM, IHD, HIV, and bronchial asthma will be excluded on the basis of history and examination.
•Pregnant and lactating women.
•Patient already taking modern medicine or will be included in the study after a washout period of 2 weeks.
•In case of worsening of the symptoms, the patient will be shifted to the standard management.

发起方

Department of Amraze Jild wa Zohrawiya Ajmal Khan Tibbiya College and Hospital AMU Aligarh